Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11286466 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis
Conditions: Hepatocellular Carcinoma;   CHILD B
Interventions: Drug: sorafenib;   Drug: Pravastatin;   Drug: Sorafenib + Pravastatin;   Other: patients receiving best supportive care

Indicates status has not been verified in more than two years